Company Profile
LadRx Stock Price, News & Analysis
- Ticker:
- LADX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.01 USD (0.00%)
Close
Last updated: June 22, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for LADX.
Company overview
Business overview
LadRx was a biotechnology company historically focused on oncology and drug delivery before becoming a legacy ticker. Its story centered on the challenge of turning a narrow therapeutic concept into durable value.
Geographic Base and Sector Classification
LadRx was headquartered in the United States and traded on NASDAQ. It sat in small-cap oncology and drug-delivery biotechnology.
Business Model Characteristics
The company depended on clinical progress, strategic changes, and capital support while advancing a narrow pipeline. Investors historically watched proof-of-concept and financing runway.
Position Within the Biotechnology Landscape
LadRx is best understood as a historical small-cap oncology biotech name. Like many micro-cap drug developers, its stock was driven by pipeline risk and capital needs.
Future catalysts
LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update. The market is focused on what value remains.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of LadRx (LADX)?
LadRx (LADX) most recently closed at 0.01 USD, a 0.00% move versus the previous session.
What does LadRx do?
LadRx was a biotechnology company historically focused on oncology and drug delivery before becoming a legacy ticker. Its story centered on the challenge of turning a narrow therapeutic concept into durable value.
On which exchange is LADX stock listed?
LadRx (LADX) is associated with NASDAQ, United States, Biopharma.
What is LadRx?
LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update.
Which conditions is LadRx targeting with LadRx?
LadRx is associated with oncology based on its company overview and current catalyst commentary.
How does LadRx describe recent progress with LadRx?
LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update.
What future catalysts are investors watching for LadRx?
LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update. The market is focused on what value remains.